Implementation of treatment guidelines for specialist mental health care

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 12, 2016, Pages

  Bighelli, Irene ^a   Ostuzzi, Giovanni ^b   Girlanda, Francesca ^c   Cipriani, Andrea ^d   Becker, Thomas ^c   Koesters, Markus ^c   Barbui, Corrado ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF ULM   (Germany)

^d WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; FOLLOW UP; HUMAN; MEDICAL EDUCATION; MEDICAL SPECIALIST; MENTAL HEALTH CARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SHARED DECISION MAKING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; MENTAL HEALTH; META ANALYSIS; PROTOCOL COMPLIANCE; SPECIALIZATION;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; MENTAL HEALTH; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SPECIALIZATION;

EID: 85006265924     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009780.pub3     Document Type: Review

References (71)

1. Baandrup L, Allerup P, Lublin H, Nordentoft M, Peacock L, Glenthoj B. Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients. Acta Psychiatrica Scandinavica 2010;122:367-74. [3115070]
2. NCT00541398 Antipsychotic polypharmacy: prevalence, background and consequences. clinicaltrials.gov/ct2/show/NCT00541398 (first received 9 October 2007). [3115071]
3. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Shared decision making and long-term outcome in schizophrenia treatment. Journal of Clinical Psychiatry 2007;68:992-7. [3115073]
4. Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatrica Scandinavica 2006;114:265-73. [3115074]
5. Hudson TJ, Owen RR, Thrush CR, Armitage TL, Thapa P. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. Journal of Clinical Psychiatry 2008;69:74-80. [3115076]
6. Owen RR, Hudson T, Thrush T, Thapa P, Armitage T, Landes RD. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia. Medical Care 2008;46:686-91. [3115077]
7. Williams DK, Thrush CR, Armitage TL, Owen RR, Hudson TJ, Thapa P. The effect of guideline implementation strategies on akathisia outcomes in schizophrenia. Journal of Applied Research 2003;4:470-82. [3115078]
8. Ince P, Tai S, Haddock G. Using plain English and behaviourally specific language to increase the implementation of clinical guidelines for psychological treatments in schizophrenia. Journal of Mental Health 2015;24(3):129-33. [3115080]
9. Michie S, Lester K. Words matter: increasing the implementation of clinical guidelines. Quality and Safety Health Care 2005;14:367-70. [3115081]
10. Osborn DPJ, Nazareth I, Wright CA, King MB. Impact of a nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomised feasibility trial of community mental health teams. BMC Health Services Research 2010;10(61):1-13. [3115083]
11. Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, et al. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. Psychological Medicine 2008;38:705-15. [3115085]
12. Azrin N, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behaviour Research and Therapy 1998;36:849-61. [3115087]
13. Brunette MF. Facilitators and barriers to implementation of coordinated specialty care in U.S. community mental health clinic. Schizophrenia Bulletin 2015;41:S304. [3115089]
14. Byng R, Jones R, Leese M, Hamilton B, McCrone P, Craig T. Exploratory cluster randomised controlled trial of shared care development for long-term mental illness. British Journal of General Practice 2004;54:259-66. [3115091]
15. De Beurs DP, De Groot MH, Bosmans JE, De Keijser J, Mokkenstorm J, Verwey B, et al. Reducing patients' suicide ideation through training mental health teams in the application of the Dutch multidisciplinary practice guideline on assessment and treatment of suicidal behavior: study protocol of a randomized controlled trial. Trials 2013;14:372. [3115093]
16. Koivunen M, Valimaki M, Patel A, Knapp M, Hatonen H, Kuosmanen L, et al. Effects of the implementation of the web-based patient support system on staff's attitudes towards computers and IT use: a randomised controlled trial. Scandinavian Journal of Caring Sciences 2010;24:592-9. [3115095]
17. Robinson DG, Schooler NR, John M, Correll CU, Marcy P, Addington J, et al. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. American Journal of Psychiatry 2015;172(3):237-48. [3115097]
18. Miller A, Crismon ML, Rush AJ, Chiles J, Kashner TM, Toprac MG, et al. The Texas medication algorithm project: clinical results for schizophrenia. Schizophrenia Bulletin 2004;30:627-47. [3115099]
19. Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, et al. Texas medication algorithm project, Phase 3 (TMAP-3): rationale and study design. Journal of Clinical Psychiatry 2003;64:357-69. [3115100]
20. Tjia J, Lemay C, Mazor KM, Briesacher BA, Field TS, Kanaan AO, et al. Dissemination of evidence-based antipsychotic prescribing guidelines to nursing homes: a cluster randomized trial. Journal of the American Geriatrics Society 2014;62:1289-98. [3115102]
21. UMIN000004931 An intervention study of optimizing algorithm-based pharmacological treatment for schizophrenia. upload.umin.ac.jp/cgi-open-bin/ctr_e/index.cgi (date of disclosure of the study information 22 January 2011). [3115104]
22. NCT00156637 A study of strategies to improve schizophrenia treatment. clinicaltrials.gov/ct2/show/NCT00156637 (first received 7 September 2005). [3115106]
23. Rosen CS, Tiet QQ, Harris AH, Julian TF, McKay JR, Moore WM, et al. Telephone monitoring and support after discharge from residential PTSD treatment: a randomized controlled trial. Psychiatric Services 2013;64(1):13-20. [3115107]
24. Young AS, Niv N, Chinman M, Dixon L, Eisen SV, Fischer EP, et al. Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI. Community Mental Health Journal 2011;47(2):123-35. [3115108]
25. Olfson M. Implementing practice guidelines for schizophrenia. 151st Annual Meeting of the American Psychiatric Association; 1998 May 30-June 4; Toronto (ON). 1998. [3115110]
26. Owen RR, Drummond KL, Viverito KM, Marchant K, Pope SK, Smith JL, et al. Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation. Implementation Science 2013;8:120. [3115112]
27. NCT00182494 A five year, prospective, randomized, blinded, controlled trial comparing the efficacy of a modified diabetes prevention protocol and the standard comprehensive outpatient care in lowering the incidence of new onset diabetes among people treated for schizophrenia and are at risk to develop type II diabetes mellitus. clinicaltrials.gov/ct2/show/NCT00182494 (first received 14 September 2005). [3115114]
28. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200. [MEDLINE: 1997074332]
29. Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophrenia Bulletin 1993;19:609-18.
30. Barbui C, Dua T, Van Ommeren M, Yasamy MT, Fleischmann A, Clark N, et al. Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLOS Medicine 2010;7(8):e1000322.
31. Barbui C, Cipriani A. What are evidence-based treatment recommendations?. Epidemiology and Psychiatric Sciences 2011;20:29-31.
32. Barbui C, Cipriani A. Cluster randomised trials. Epidemiology and Psychiatric Sciences 2011;20:307-9.
33. Barbui C, Koesters M, Cipriani A. Implementation of treatment guidelines for specialist mental health care. Cochrane Database of Systematic Reviews 2012, Issue 4.[DOI:10.1002/14651858.CD009780]
34. Barbui C, Tansella M. Guideline implementation in mental health: current status and future goals. Epidemiology and Psychiatric Sciences 2012;21:227-9.
35. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-11.
36. Cipriani A, Geddes JR. What is a randomised controlled trial?. Epidemiology and Psychiatric Sciences 2009;18:191-4.
37. Cipriani A, Furukawa TA. Advancing evidence-based practice to improve patient care. Evidence Based Mental Health 2014;17(1):1-2.
38. Deeks J. Issues in the selection for meta-analyses of binary data. 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town (SA). Cochrane Collaboration, 2000.
39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
40. Fretheim A, Schünemann HJ, Oxman AD. Improving the use of research evidence in guideline development. 15. Disseminating and implementing guidelines. Health Research Policy and Systems 2006;4:27.
41. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59:7-10.
42. Gagliardi AR. Translating knowledge to practice: optimizing the use of guidelines. Epidemiology and Psychiatric Sciences 2012;21(3):231-6. [DOI: 10.1017/S2045796012000212]
43. Girlanda F, Fiedler I, Ay E, Barbui C, Koesters M. Guideline implementation strategies for specialist mental healthcare. Current Opinion in Psychiatry 2013;26(4):369-75.
44. Girlanda F, Fiedler I, Becker T, Barbui C, Koesters M. The evidence-practice gap in specialist mental healthcare: a systematic review and meta-analysis of guideline implementation studies. British Journal of Psychiatry 2016 Jul 21 [Epub ahead of print]. [DOI:10.1192/bjp.bp.115.179093]
45. GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
46. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 2004;8(6):1-72.
47. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30.
48. Grol 2008. Knowledge transfer in mental health care: how do we bring evidence into day-to-day practice?. Canadian Journal of Psychiatry 2008;53:275-6.
49. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383-94.
50. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
51. Higgins JPT, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (update March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
52. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987;13:261-76.
53. Knaup C, Koesters M, Schoefer D, Becker T, Puschner B. Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. British Journal of Psychiatry 2009;195:15-22.
54. Langewitz W, Keller A, Denz M, Wossmer-Buntschu B, Kiss A. The patient satisfaction questionnaire: a suitable tool for quality control in the physician-patient relationship?. Psychotherapy and Psychosomatic Medicine and Psychology 1995;45:351-7.
55. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
56. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856]
57. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
58. Michie S, Lester K. Words matter: increasing the implementation of clinical guidelines. Quality and Safety Health Care 2005;14:367-70. [3115081]
59. National Institute for Health and Clinical Excellence. Psychosis and Schizophrenia in Adults. Treatment and Management. The British Psychological Society and The Royal College of Psychiatrists, 2014.
60. Ostuzzi G, Bighelli I, Carrara BV, Dusi N, Imperadore G, Lintas C, et al. Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare. International Journal of Mental Health Systems 2013;7:14.
61. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10:799-812.
62. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
63. Sederer LI. Science to practice: making what we know what we actually do. Schizophrenia Bulletin 2009;35:714-8.
64. Tansella M, Thornicroft G. Implementation science: understanding the translation of evidence into practice. British Journal of Psychiatry 2009;195:283-5.
65. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92.
66. Välimäki M, Hätönen H, Lahti M, Kuosmanen L, Adams CE. Information and communication technology in patient education and support for people with schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD007198.pub2]
67. Weinmann S, Koesters M, Becker T. Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatrica Scandinavica 2007;115:420-33.
68. World Health Organization. MhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings. Geneva: World Health Organization, 2010.
69. World Health Organization. WHO mhGAP Guideline Update. Update of the Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance use Disorder. Geneva: World Health Organization, 2015.
70. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. Losing participants before trial ends erodes credibility of finding. Psychiatric Bulletin 2009;33(7):254-7.
71. Barbui C, Girlanda F, Ay E, Cipriani A, Becker T, Koesters M. Implementation of treatment guidelines for specialist mental health care. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI:10.1002/14651858.CD009780.pub2]